Combined BRAF and MEK Inhibition with Dabrafenib and Trametinib in BRAF V600-mutant colorectal cancer

被引：0
|
作者：
Loir, E. [1 ]
Cochereau, D. [1 ]
机构：
[1] AERIO, Paris, France
来源：
ONCOLOGIE | 2016年 / 18卷 / 9-10期
关键词：
IMPROVED SURVIVAL; VEMURAFENIB; MELANOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [1] Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
    Corcoran, Ryan B.
    Atreya, Chloe E.
    Falchook, Gerald S.
    Kwak, Eunice L.
    Ryan, David P.
    Bendell, Johanna C.
    Hamid, Omid
    Messersmith, Wells A.
    Daud, Adil
    Kurzrock, Razelle
    Pierobon, Mariaelena
    Sun, Peng
    Cunningham, Elizabeth
    Little, Shonda
    Orford, Keith
    Motwani, Monica
    Bai, Yuchen
    Patel, Kiran
    Venook, Alan P.
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 4023 - +
  • [2] Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
    Subbiah, Vivek
    Kreitman, Robert J.
    Wainberg, Zev A.
    Cho, Jae Yong
    Schellens, Jan H. M.
    Soria, Jean Charles
    Wen, Patrick Y.
    Zielinski, Christoph
    Cabanillas, Maria E.
    Urbanowitz, Gladys
    Mookerjee, Bijoyesh
    Wang, Dazhe
    Rangwala, Fatima
    Keam, Bhumsuk
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (01) : 7 - +
  • [3] Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
    Long, Georgina V.
    Weber, Jeffrey S.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Daud, Adil
    Gonzalez, Rene
    Sosman, Jeffrey A.
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Kefford, Richard F.
    Lawrence, Donald
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald S.
    Algazi, Alain
    Lewis, Karl
    Puzanov, Igor
    Ibrahim, Nageatte
    Sun, Peng
    Cunningham, Elizabeth
    Kline, Amy S.
    Buono, HeatherDel
    OpattMcDowell, Diane
    Patel, Kiran
    Flaherty, Keith T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) : 871 - +
  • [4] Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
    Long, Georgina, V
    Eroglu, Zeynep
    Infante, Jeffrey
    Patel, Sapna
    Daud, Adil
    Johnson, Douglas B.
    Gonzalez, Rene
    Kefford, Richard
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Sharfman, William
    McWilliams, Robert
    Sznol, Mario
    Redhu, Suman
    Gasal, Eduard
    Mookerjee, Bijoyesh
    Weber, Jeffrey
    Flaherty, Keith T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07) : 667 - +
  • [5] Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
    Johnson, Douglas B.
    Flaherty, Keith T.
    Weber, Jeffrey S.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Kefford, Richard F.
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Sharfman, William H.
    McWilliams, Robert R.
    Sznol, Mario
    Lawrence, Donald P.
    Gibney, Geoffrey T.
    Burris, Howard A., III
    Falchook, Gerald S.
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Patel, Kiran
    Ibrahim, Nageatte
    Sun, Peng
    Little, Shonda
    Cunningham, Elizabeth
    Sosman, Jeffrey A.
    Daud, Adil
    Gonzalez, Rene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (33) : 3697 - +
  • [6] First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma
    Kim, Chang Gon
    Kim, Miso
    Hwang, Jieon
    Kim, Seung Tae
    Jung, Minkyu
    Kim, Kyoo Hyun
    Kim, Kyung Hwan
    Chang, Jee Suk
    Koom, Woong Sub
    Roh, Mi Ryung
    Chung, Kee Yang
    Kim, Tae Min
    Kim, Sang Kyum
    Lee, Jeeyun
    Shin, Sang Joon
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (05) : 989 - 996
  • [7] The effects of dabrafenib and/or trametinib treatment in Braf V600-mutant glioma: a systematic review and meta-analysis
    Lei, Jun
    Liu, Yanhui
    Fan, Yingjun
    [J]. NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [8] BRAF-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer
    Middleton, Gary
    Yang, Yiqun
    Campbell, Catarina D.
    Andre, Thierry
    Atreya, Chloe E.
    Schellens, Jan H. M.
    Yoshino, Takayuki
    Bendell, Johanna C.
    Hollebecque, Antoine
    McRee, Autumn J.
    Siena, Salvatore
    Gordon, Michael S.
    Tabernero, Josep
    Yaeger, Rona
    O'Dwyer, Peter J.
    De Vos, Filip
    Van Cutsem, Eric
    Millholland, John M.
    Brase, Jan C.
    Rangwala, Fatima
    Gasal, Eduard
    Corcoran, Ryan B.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (11) : 2466 - 2476
  • [9] Combined BRAF, MEK, and heat-shock protein 90 (HSP90) inhibition in advanced BRAF V600-mutant melanoma
    Eroglu, Zeynep
    Chen, Y. Ann
    Smalley, Inna
    Li, Jiannong
    Markowitz, Joseph K.
    Brohl, Andrew S.
    Tetteh, Leticia
    Taylor, Hayley
    Sondak, Vernon K.
    Khushalani, Nikhil I.
    Smalley, Keiran S. M.
    [J]. CANCER, 2024, 130 (02) : 232 - 243
  • [10] Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma
    Bouffet, Eric
    Geoerger, Birgit
    Moertel, Christopher
    Whitlock, James A.
    Aerts, Isabelle
    Hargrave, Darren
    Osterloh, Lisa
    Tan, Eugene
    Choi, Jeea
    Russo, Mark
    Fox, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 664 - +
12345